147 related articles for article (PubMed ID: 23708102)
1. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
[TBL] [Abstract][Full Text] [Related]
2. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
[TBL] [Abstract][Full Text] [Related]
3. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
[TBL] [Abstract][Full Text] [Related]
5. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.
Gao J; Hu Z; Liu J; Liu D; Wang Y; Cai M; Zhang D; Tan M; Lin B
Med Oncol; 2014 May; 31(5):920. PubMed ID: 24692145
[TBL] [Abstract][Full Text] [Related]
7. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
[TBL] [Abstract][Full Text] [Related]
8. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B
J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446
[TBL] [Abstract][Full Text] [Related]
9. High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers.
Hu Z; Gao J; Zhang D; Liu Q; Yan L; Gao L; Liu J; Liu D; Zhang S; Lin B
PLoS One; 2013; 8(2):e57250. PubMed ID: 23468946
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
Shuang T; Wang M; Zhou Y; Shi C
Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
[TBL] [Abstract][Full Text] [Related]
11. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
[TBL] [Abstract][Full Text] [Related]
12. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.
Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
[TBL] [Abstract][Full Text] [Related]
13. Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.
Ricardo S; Marcos-Silva L; Valente C; Coelho R; Gomes R; David L
Virchows Arch; 2016 Jun; 468(6):715-22. PubMed ID: 27003157
[TBL] [Abstract][Full Text] [Related]
14. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.
Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601
[TBL] [Abstract][Full Text] [Related]
15. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
[TBL] [Abstract][Full Text] [Related]
16. Expression of NF-κB and PTEN in primary epithelial ovarian carcinoma and the correlation with chemoresistance.
Wang L; Wang C; Jin S; Qu D; Ying H
Int J Clin Exp Pathol; 2015; 8(9):10953-63. PubMed ID: 26617813
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of Lewis y and integrin α5β1 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma.
Hu Z; Gao S; Gao J; Hou R; Liu C; Liu J; Li B; Liu D; Zhang S; Lin B
Int J Mol Sci; 2012 Nov; 13(12):15588-600. PubMed ID: 23443083
[TBL] [Abstract][Full Text] [Related]
18. URG4 upregulation is associated with tumor growth and poor survival in epithelial ovarian cancer.
Li W; Zhou N
Arch Gynecol Obstet; 2012 Jul; 286(1):209-15. PubMed ID: 22395861
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
[TBL] [Abstract][Full Text] [Related]
20. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
